Neurological Disorder & HBOT

Approximately 1 billion people of all ages are currently affected by neurological disorders, with an estimated 6.8 million related deaths that occur every year world-wide. This staggering statistical evidence illustrates the substantial impact of neurological disorders. New evidence presents how hyperbaric oxygen therapy (HBOT) is helping individuals regain neurological activity and functionality. For neuro-developmental and neuro-degenerative disorders, in addition to neurological injuries, HBOT provides the brain with increased levels of oxygen to help recover/repair brain tissue, increase neuronal stem cell growth and improve cognitive functioning.

Clinical studies have demonstrated the benefits of HBOT for neurological conditions with the following:

• Brain Functioning & Performance
• Brain Repair & Recovery
• Neuro-Inflammation
• Regeneration of the Nervous System
• Neurological Conditions

HBOT has been shown to be an effective solution when it comes to neurological conditions. Some of those include:

Brain Functioning & Performance

• Increases Circulatory Pathways in the Brain
• Enhance Memory and Mental Performance
• Improves Oxygenation to the Brain

Brain Repair & Recovery

• Recovers and repairs damaged brain tissue
• Develops and regains cognitive/motor functions

Neuro-Inflammation

• Reduces cerebral edema, decreases intracranial pressure
• Reduces cerebral infarction
• Reduces blood-brain barrier breakdown
• Minimizes oxidative stress

Nervous System

• Stimulates the Creation of New Brain Cells
• Facilitates the Formation of New Brain Connections
• Promotes the Construction of New Brain Tissue

Neurological Conditions

• Neuro-developmental conditions (autism, cerebral palsy, fetal alcohol syndrome)
• Neurodegenerative conditions (alzheimer’s, parkinson’s, huntington’s disease)
• Neurological injuries (stroke, traumatic brain and spinal cord injuries, concussions)

Study: HBOT Improves Brain Function

A prospective, randomized, crossover, controlled trial was published in 2013 testing the effectiveness of HBOT for improving brain function and quality of life for mild-traumatic brain injured (mTBI) patients suffering chronic neurocognitive impairments. A total of 56 mTBI patients, 1-5 years after injury, with prolonged post-concussion syndrome were evaluated. Patients in the treated group were assessed at baseline and after 40 HBOT sessions. Whereas patients in the crossover group were evaluated three times: at baseline, after a two-month control period of no HBOT and after two months of 40 HBOT sessions.

Significant improvements were confirmed in cognitive function and quality of life in both groups after HBOT; however, no significant improvement was observed following the control period. HBOT was shown to induce significant brain function improvements, neuroplasticity and increased brain activity according to SPECT imaging.